| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2004PNAS..10111064C |
| P356 | DOI | 10.1073/PNAS.0402455101 |
| P932 | PMC publication ID | 503741 |
| P698 | PubMed publication ID | 15263096 |
| P5875 | ResearchGate publication ID | 8446669 |
| P50 | author | Gianluigi Mancardi | Q42463501 |
| Angela Pistorio | Q56458832 | ||
| Antonio Uccelli | Q57007173 | ||
| Debora Giunti | Q73056631 | ||
| P2093 | author name string | Claudio Gambini | |
| Vito Pistoia | |||
| Anna Corcione | |||
| Elisa Ferretti | |||
| Simona Casazza | |||
| Emanuela Zappia | |||
| P2860 | cites work | Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis | Q22252943 |
| Transcriptional analysis of the B cell germinal center reaction | Q24554209 | ||
| Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event | Q28186287 | ||
| CCL9 is secreted by the follicle-associated epithelium and recruits dome region Peyer's patch CD11b+ dendritic cells | Q28205502 | ||
| CCL19 and CXCL12 trigger in vitro chemotaxis of human mantle cell lymphoma B cells | Q28244007 | ||
| Germinal centers | Q29616234 | ||
| Pathways of fluid drainage from the brain--morphological aspects and immunological significance in rat and man | Q30985026 | ||
| Restricted use of VH4 germline segments in an acute multiple sclerosis brain | Q32107477 | ||
| The role of B cells and autoantibodies in multiple sclerosis | Q33942290 | ||
| Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. | Q34191599 | ||
| Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix | Q34280514 | ||
| Analysis of somatic mutation in five B cell subsets of human tonsil | Q34328629 | ||
| Ectopic lymphoid organogenesis: a fast track for autoimmunity | Q34363840 | ||
| Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen | Q34488105 | ||
| Three or more routes for leukocyte migration into the central nervous system | Q35183162 | ||
| Memory B lymphocytes migrate to bone marrow in humans | Q35905551 | ||
| Ectopic LTαβ Directs Lymphoid Organ Neogenesis with Concomitant Expression of Peripheral Node Addressin and a HEV-restricted Sulfotransferase | Q36370988 | ||
| B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin alpha-dependent fashion. | Q36400576 | ||
| The Development of Rational Strategies for Selective Immunotherapy against Autoimmune Demyelinating Disease | Q36665881 | ||
| Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis. | Q37385073 | ||
| Immunoglobulin-containing cells in multiple-sclerosis plaques | Q39450637 | ||
| Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis | Q40141450 | ||
| TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro. | Q40647455 | ||
| Regulation of CD27 expression in the course of germinal center B cell differentiation: the pivotal role of IL-10. | Q40861806 | ||
| Lymphotoxin alpha3 induces chemokines and adhesion molecules: insight into the role of LT alpha in inflammation and lymphoid organ development | Q40986515 | ||
| Germinal center development | Q41583265 | ||
| B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions | Q41697260 | ||
| Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells | Q42108183 | ||
| Germinal center founder cells display propensity for apoptosis before onset of somatic mutation | Q42114332 | ||
| Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients | Q42619341 | ||
| Identification of autoantibodies associated with myelin damage in multiple sclerosis | Q46424597 | ||
| Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. | Q47357498 | ||
| Heterogeneity of tonsillar subepithelial B lymphocytes, the splenic marginal zone equivalents | Q47859763 | ||
| MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study | Q47877446 | ||
| Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients--diagnostic and clinical implications. | Q47901564 | ||
| Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. | Q48325664 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| Chemotaxis of human tonsil B lymphocytes to CC chemokine receptor (CCR) 1, CCR2 and CCR4 ligands is restricted to non-germinal center cells. | Q52011406 | ||
| Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjögren's syndrome. | Q52017280 | ||
| Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2. | Q52054113 | ||
| Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions | Q73223366 | ||
| Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue | Q74016845 | ||
| Chemokines in inflammation and immunity | Q74206737 | ||
| Activation-dependent modulation of B lymphocyte migration to chemokines | Q74247915 | ||
| Evolution of autoantibody responses via somatic hypermutation outside of germinal centers | Q74813307 | ||
| Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C | Q77933533 | ||
| P433 | issue | 30 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell differentiation | Q210861 |
| patient | Q181600 | ||
| nervous system | Q9404 | ||
| multiple sclerosis | Q8277 | ||
| P304 | page(s) | 11064-11069 | |
| P577 | publication date | 2004-07-19 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis | |
| P478 | volume | 101 |
| Q47590508 | A Neuroprimer: Principles of Central Nervous System Immunity |
| Q37818921 | A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis |
| Q40530656 | Activated GL7+ B cells are maintained within the inflamed CNS in the absence of follicle formation during viral encephalomyelitis. |
| Q80767685 | Analysis of cerebrospinal fluid cell populations with monoclonal antibodies |
| Q36484465 | Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials |
| Q35891689 | Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein |
| Q33745475 | Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid |
| Q35758506 | Antigen microarrays identify CNS-produced autoantibodies in RRMS. |
| Q42665157 | Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions |
| Q24628925 | Atacicept: targeting B cells in multiple sclerosis |
| Q26770852 | B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation |
| Q37093281 | B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity |
| Q37400354 | B cell characterization and reactivity analysis in multiple sclerosis |
| Q36091161 | B cell proliferation, somatic hypermutation, class switch recombination, and autoantibody production in ectopic lymphoid tissue in murine lupus |
| Q36220292 | B cell repertoire expansion occurs in meningeal ectopic lymphoid tissue. |
| Q38050398 | B cells and antibodies in multiple sclerosis pathogenesis and therapy |
| Q42249555 | B cells as a target of immune modulation |
| Q34544062 | B cells move to centre stage: novel opportunities for autoimmune disease treatment |
| Q51033051 | B-cell subsets up-regulate α4 integrin and accumulate in the cerebrospinal fluid in clinically isolated syndrome suggestive of multiple sclerosis onset |
| Q36981274 | B-cells and humoral immunity in multiple sclerosis. Implications for therapy |
| Q24646563 | BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma |
| Q27496017 | Biomarkers in Multiple Sclerosis: An Up-to-Date Overview |
| Q46275246 | CNS viral infection diverts homing of antibody-secreting cells from lymphoid organs to the CNS. |
| Q37990784 | CXCL12 in control of neuroinflammation. |
| Q92238833 | CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond |
| Q35086918 | CXCL13 antibody for the treatment of autoimmune disorders |
| Q36788638 | CXCL13 promotes isotype-switched B cell accumulation to the central nervous system during viral encephalomyelitis |
| Q30498100 | Ccl22/MDC, is a prostaglandin dependent pyrogen, acting in the anterior hypothalamus to induce hyperthermia via activation of brown adipose tissue |
| Q47356888 | Cerebrospinal Fluid Cytokine Expression Profile in Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy. |
| Q41255081 | Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study. |
| Q21144285 | Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis |
| Q36082102 | Cerebrospinal fluid B cells from multiple sclerosis patients are subject to normal germinal center selection. |
| Q35947260 | Chemokine signatures in the skin disorders of Lyme borreliosis in Europe: predominance of CXCL9 and CXCL10 in erythema migrans and acrodermatitis and CXCL13 in lymphocytoma |
| Q48701331 | Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment |
| Q92538902 | Chronic Inflammation: A Common Promoter in Tertiary Lymphoid Organ Neogenesis |
| Q36086261 | Chronic hepatitis C virus infection breaks tolerance and drives polyclonal expansion of autoreactive B cells |
| Q47935420 | Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients. |
| Q36827362 | Current concepts of the cellular and molecular pathophysiology of multiple sclerosis |
| Q37111883 | DNA-based vaccines: the future of multiple sclerosis therapy? |
| Q40619934 | Demyelinating strain of mouse hepatitis virus infection bridging innate and adaptive immune response in the induction of demyelination |
| Q36097325 | Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases |
| Q37867728 | Development of anti-CD20 therapy for multiple sclerosis. |
| Q30598338 | Diagnostic biomarkers in multiple sclerosis. |
| Q50860736 | Differential effects of fingolimod on B-cell populations in multiple sclerosis. |
| Q37328280 | Disease-modifying agents for multiple sclerosis: recent advances and future prospects |
| Q38198016 | Does disease-irrelevant intrathecal synthesis in multiple sclerosis make sense in the light of tertiary lymphoid organs? |
| Q21261385 | Early B-cell Factor gene association with multiple sclerosis in the Spanish population |
| Q37075235 | Ectopic lymphoid tissues and local immunity |
| Q35099828 | Effect of met-enkephalin on chromosomal aberrations in the lymphocytes of the peripheral blood of patients with multiple sclerosis |
| Q38091729 | Effects of CXCL13 inhibition on lymphoid follicles in models of autoimmune disease |
| Q37778622 | Emerging concepts in autoimmune encephalomyelitis beyond the CD4/TH1 paradigm |
| Q26830464 | Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation |
| Q35231795 | Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosis |
| Q35077861 | Expansion of CD27high plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutation. |
| Q34449329 | Extensive grey matter pathology in the cerebellum in multiple sclerosis is linked to inflammation in the subarachnoid space |
| Q34742821 | Factors supporting intrathecal humoral responses following viral encephalomyelitis. |
| Q37875022 | Flow cytometric characterization of cerebrospinal fluid cells |
| Q36302329 | Follicular B helper T cells in antibody responses and autoimmunity. |
| Q36919822 | Glial cell activation, recruitment, and survival of B-lineage cells following MCMV brain infection |
| Q36778303 | High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients. |
| Q28750403 | IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome |
| Q42259604 | Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases |
| Q34251673 | Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis. |
| Q36577275 | Immunopathogenesis and immunotherapy of multiple sclerosis |
| Q55039421 | Immunophenotypic characterization of CSF B cells in virus-associated neuroinflammatory diseases. |
| Q36286321 | In situ single cell detection via microfluidic magnetic bead assay |
| Q37655201 | Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study. |
| Q35764685 | Inflammatory cortical demyelination in early multiple sclerosis |
| Q37354974 | Inhibition of LTi cell development by CD25 blockade is associated with decreased intrathecal inflammation in multiple sclerosis |
| Q92642889 | Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis |
| Q42232853 | Intrahepatic B-cell follicles of chronically hepatitis C virus-infected individuals lack signs of an ectopic germinal center reaction. |
| Q59355260 | Intrathecal B Cells in MS Have Significantly Greater Lymphangiogenic Potential Compared to B Cells Derived From Non-MS Subjects |
| Q36142794 | Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis |
| Q40272576 | Intrathecal chitotriosidase and the outcome of multiple sclerosis |
| Q38084075 | Intrathecal humoral immunity to encephalitic RNA viruses. |
| Q44681284 | Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation |
| Q33565842 | Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS. |
| Q37523986 | Kv1.3 potassium channels as a therapeutic target in multiple sclerosis |
| Q44121733 | Leukocyte entry into the CNS of Leishmania chagasi naturally infected dogs. |
| Q64066412 | Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis |
| Q35563291 | Loureirin B, an essential component of Sanguis Draxonis, inhibits Kv1.3 channel and suppresses cytokine release from Jurkat T cells |
| Q37186200 | Lymphoid chemokines in chronic neuroinflammation |
| Q34020894 | Lymphoid chemokines in the CNS. |
| Q36405080 | Lymphoid neogenesis in chronic inflammatory diseases. |
| Q48489792 | Magnetic resonance evidence of cortical onset of multiple sclerosis |
| Q35755470 | Measles virus-specific plasma cells are prominent in subacute sclerosing panencephalitis CSF |
| Q36097332 | Meningeal Infiltration of the Spinal Cord by Non-Classically Activated B Cells is Associated with Chronic Disease Course in a Spontaneous B Cell-Dependent Model of CNS Autoimmune Disease |
| Q48949792 | Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis |
| Q36572543 | Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology |
| Q35756367 | N-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3. |
| Q44938493 | Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patients |
| Q36991434 | New insights into adaptive immunity in chronic neuroinflammation |
| Q37313911 | Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary |
| Q42566452 | Pathogenic antibodies are active participants in spinal cord injury |
| Q24642165 | Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis |
| Q42264060 | Phenotypic and functional characterization of switch memory B cells from patients with oligoarticular juvenile idiopathic arthritis |
| Q28281365 | Potassium channels, memory T cells, and multiple sclerosis |
| Q90429566 | Potential Biomarker and Therapeutic LncRNAs in Multiple Sclerosis Through Targeting Memory B Cells |
| Q39084950 | Potential importance of B cells in aging and aging-associated neurodegenerative diseases |
| Q64249132 | Presence of intragraft B cells during acute renal allograft rejection is accompanied by changes in peripheral blood B cell subsets |
| Q34059107 | Progression from IgD+ IgM+ to isotype-switched B cells is site specific during coronavirus-induced encephalomyelitis. |
| Q35126686 | Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease. |
| Q41933450 | Protective Humoral Immunity in the CNS Requires Peripheral CD19-Dependent Germinal Center Formation Following Coronavirus Encephalomyelitis. |
| Q37019872 | Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis |
| Q36607157 | Recruitment and retention of B cells in the central nervous system in response to alphavirus encephalomyelitis |
| Q36832863 | Role of B cells in pathogenesis of multiple sclerosis |
| Q57825775 | Role of CXCL13 in the formation of the meningeal tertiary lymphoid organ in multiple sclerosis |
| Q38530157 | Role of T Follicular Helper cells in Multiple Sclerosis |
| Q52657141 | Role of TFH Cells in Promoting T Helper 17-Induced Neuroinflammation. |
| Q33264770 | Screening random peptide libraries with subacute sclerosing panencephalitis brain-derived recombinant antibodies identifies multiple epitopes in the C-terminal region of the measles virus nucleocapsid protein |
| Q42373792 | Selective intrathecal enrichment of G1m1-positive B cells in multiple sclerosis |
| Q38690022 | Targeting B cells in relapsing-remitting multiple sclerosis: from pathophysiology to optimal clinical management. |
| Q28303760 | Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases |
| Q51976995 | Tertiary lymphoid tissues generate effector and memory T cells that lead to allograft rejection. |
| Q36474316 | The B cell response in multiple sclerosis |
| Q26776542 | The Ins and Outs of B Cells in Multiple Sclerosis |
| Q36216025 | The Role of Latently Infected B Cells in CNS Autoimmunity |
| Q90050404 | The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases |
| Q82719617 | The SDF-1 3'a genetic variation of the chemokine SDF-1α (CXCL12) in parallel with its increased circulating levels is associated with susceptibility to MS: a study on Iranian multiple sclerosis patients |
| Q47116115 | The chronically inflamed central nervous system provides niches for long-lived plasma cells |
| Q92213495 | The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis |
| Q35155753 | The double-edged sword of autoimmunity: lessons from multiple sclerosis |
| Q37818131 | The potential role of B cell-targeted therapies in multiple sclerosis |
| Q38092972 | The utility of cerebrospinal fluid analysis in patients with multiple sclerosis |
| Q38560936 | Thyroid Hormone Potentially Benefits Multiple Sclerosis via Facilitating Remyelination. |
| Q36492380 | Toward biomarkers in multiple sclerosis: new advances. |
| Q46927946 | Unaltered levels of transplant arteriosclerosis in the absence of the B cell homing chemokine receptor CXCR5. |
| Q35463552 | Update on the autoimmune pathology of multiple sclerosis: B-cells as disease-drivers and therapeutic targets |
| Q40053831 | Use of rituximab in multiple sclerosis: current progress and future perspectives |
| Q57001708 | Viruses and multiple sclerosis |
| Q83274218 | [Rituximab in treatment for neuroimmunological diseases] |
| Q51958899 | [Targeting B cells in multiple sclerosis. Current concepts and strategies]. |
Search more.